integrative psych solutions LLC

37 washington square west
suite 1d
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 18, 2013

NYS DOS ID#
4390782

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - INTEGRATIVE PSYCH SOLUTIONS LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Judge orders psych exam for jailed Pharma Bro
    By Emily Saul - Wednesday Sep 20, 2017

    A Brooklyn federal court judge has ordered a psychiatric exam for “pharma felon” Martin Shkreli, court records show. The order comes as the 34-year-old disgraced pharmaceuticals exec languishes in ?a ?maximum security ?jail ?in Brooklyn after Judge Kiyo Matsumoto ordered his $5 million bond revoked for a Facebook post offering $5,000 per strand of former...

    Source: New York Post: Business
  • FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb
    By Ben Fidler - Wednesday Aug 23, 2017

    The FDA has just lowered a key barrier standing between Intra-Cellular Therapies and potential approval of an experimental schizophrenia drug. Now the question is whether the mixed set of data the company has accrued to support the program will be good enough for regulators. Intra-Cellular (NASDAQ: ITCI) said the FDA has finished looking over responses […]

    Source: Xconomy New York
  • Welcome to our latest alliance and GCP customer: Marketo
    Thursday Aug 24, 2017

    Source: The Official Google Blog